Johnson & Johnson names Tom Cavanaugh EVP, worldwide chairman of Innovative Medicine as Taubert retires - JNJ News | RalliesJohnson & Johnson names Tom Cavanaugh EVP, worldwide chairman of Innovative Medicine as Taubert retires
J
JNJ• Leadership change at Innovative Medicine
- Johnson & Johnson EVP Jennifer Taubert will retire as worldwide chairman of Innovative Medicine following a 21-year tenure.
- Tom Cavanaugh will succeed Taubert as EVP, worldwide chairman of Innovative Medicine effective Sept. 1, 2026.
- Cavanaugh currently serves as company group chairman, North America, Innovative Medicine.
- He joined the company in 2017, holding senior leadership roles in oncology, immunology, global commercial strategy.
- Before joining, he spent nearly 15 years at Celgene across product development, medical affairs, marketing, regional management in Spain, the U.S.
TOL
•
